in the present studies the in vivo and in vitro effects of erythromycin a and azithromycin , a new type of macrolide ( fig . 2 . ) , were investigated upon extracellular release of lysosomal enzymes , beta-glucuronidase ( beta-gluc ) and beta-n-acetylglucosaminidase ( beta-glm ) by using two experimental model systems : in vivo-adjuvant-induced arthritis in rats and in vitro- human polymorphonuclear leucocytes ( pmnl ) exposed to bovine serum albumin/anti-bovine serum albumin ( bsa/anti-bsa ) , immune complex .
C0014806
erythromycin
C0052796
azithromycin